Share Talk – Steve Shares
Welcome, the publication is an interactive weekly update on what’s happening with the trending stocks this week. I highlight and comment on the stocks that you want me to highlight or comment on. The more you speak the more I Share!
UK Oil & Gas Investments PLC (London AIM and NEX: UKOG) is delighted to announce that mobile light oil has been observed seeping from open natural fractures in Kimmeridge Limestone 4 (“KL4”) core samples at its 100%-owned Broadford Bridge-1 (“BB-1”) exploration well.
Share Talk have followed Jeff Smith and his not-for-profit organisation Big Moose since he compered our Investor Show in Cardiff earlier this year. His latest (of many) projects was a small matter of climbing Mt Everest. We are a little late on this one (sorry!) but here is Jeff’s first blog since returning home having successfully completed his mission.
Red Rock Resources Plc, the natural resource development company with interests in gold, manganese and oil production, announces that it has entered into financing agreements under which it will fund Steelmin Limited (“Steelmin”) to complete the refurbishment and recommissioning of a ferrosilicon smelter in Jajce, Bosnia, and acquire an interest in Steelmin.
TrueLayer, a London startup that’s built a developer platform to make it easy for fintech companies to access bank APIs — and ride the PSD2 gravy train — has raised $3 million in Series A funding.
Technology firm Imagination Tech is now looking to sell itself after being dumped by major customer Apple. It proves the need to look at how diversified a company’s revenues are when buying stocks. Plus, ‘new balls please’, ouch! Tennis legend Boris Becker’s bankruptcy.
Share talk spoke to Justin Tooth, Executive Chairman of FCR. We talk about yesterdays RNS covering the update on the Toral project and the appointment of Mr Campion and how that fits in with the strategy of FCR.
Parexel International is being snapped up by private equity group Pamplona Capital Management in a deal valued at around $5 billion, including debt, marking further consolidation of the contract research sector. The groups have signed a definitive agreement under which Pamplona will acquire all of the outstanding shares of the global biopharmaceutical services provider for $88.10 per share in cash.
This excellent article from Bloomberg’s Energy Finance shows why renewables will be cheaper almost everywhere in just a few years.
For the first time in 10 years global sales of pharmaceuticals are forecast by Evaluate to take a downturn because of growing pricing pressures.Analysts at the group are projecting that sales will hit $1.06 trillion in 2022, down from the $1.12 trillion forecast last year for the same period.